Michael Campbell to Tumor Microenvironment
This is a "connection" page, showing publications Michael Campbell has written about Tumor Microenvironment.
Connection Strength
1.608
-
Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM, Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer. Cell Rep Med. 2024 Nov 19; 5(11):101799.
Score: 0.787
-
Mori H, Bolen J, Schuetter L, Massion P, Hoyt CC, VandenBerg S, Esserman L, Borowsky AD, Campbell MJ. Characterizing the Tumor Immune Microenvironment with Tyramide-Based Multiplex Immunofluorescence. J Mammary Gland Biol Neoplasia. 2020 12; 25(4):417-432.
Score: 0.608
-
Liu NM, Sholevar CJ, Karimzadeh M, Uppuluri J, Van Dongen C, Graves CE, Campbell MJ, Zamora AE, Judge SJ, Canter RJ. The Immune Biology of the Adrenal Gland Microenvironment and Its Role in Metastatic Progression. Int J Mol Sci. 2026 Jan 23; 27(3).
Score: 0.214